Prevent Acute Chest Syndrome checklist (PACScheck): A quality improvement initiative to reduce acute chest syndrome

IF 2.4 3区 医学 Q2 HEMATOLOGY Pediatric Blood & Cancer Pub Date : 2024-10-17 DOI:10.1002/pbc.31378
Kerry Morrone, Kaitlin Strumph, Catherine Pisacano, Jessica Briggs, Rachelle Zipper, Bhaumik B. Patel, Susanna Chang, Wen-Ling Kyon, Kristen Ronca, Miranda Abyazi, Geoffrey Cheng, Leya Schwartz, Jennifer De Los Santos, Janine Keenan, Marina Reznik, Deepa Manwani, Michael L. Rinke
{"title":"Prevent Acute Chest Syndrome checklist (PACScheck): A quality improvement initiative to reduce acute chest syndrome","authors":"Kerry Morrone,&nbsp;Kaitlin Strumph,&nbsp;Catherine Pisacano,&nbsp;Jessica Briggs,&nbsp;Rachelle Zipper,&nbsp;Bhaumik B. Patel,&nbsp;Susanna Chang,&nbsp;Wen-Ling Kyon,&nbsp;Kristen Ronca,&nbsp;Miranda Abyazi,&nbsp;Geoffrey Cheng,&nbsp;Leya Schwartz,&nbsp;Jennifer De Los Santos,&nbsp;Janine Keenan,&nbsp;Marina Reznik,&nbsp;Deepa Manwani,&nbsp;Michael L. Rinke","doi":"10.1002/pbc.31378","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Acute chest syndrome (ACS) is a life-threatening complication of sickle cell disease (SCD). The Prevent Acute Chest Syndrome checklist (PACScheck) was created to drive appropriate ordering of opioids, incentive spirometry (IS), intravenous fluids (IVF), evaluation of oxygen desaturation, and bronchodilator use.</p>\n </section>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Decrease the development of ACS by 5% in a hospitalized pediatric SCD population.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A multidisciplinary team conducted a quality improvement (QI) project between April 2020 and August 2021 on an inpatient pediatric hematology unit. At-risk hospitalizations were patients with SCD who did not have ACS upon hospital admission. PACScheck was implemented and weekly run charts assessed documentation. Process control (p) charts, geometric control (g) charts, and chi-square tests assessed checklist process measures pre- and post-PACScheck. G chart assessed the number of encounters between ACS events.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 483 at-risk hospitalizations were identified in the 12 months prior and 363 during the study period. A g chart demonstrated that fewer encounters developed ACS during PACScheck. A p chart demonstrated that IS documentation increased during PACScheck. A run chart of PACScheck documentation demonstrated a median of 100% documentation at least once per hospitalization during the last six months of the intervention.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Development of ACS can be reduced by implementing a best-practices checklist (PACScheck) on an inpatient pediatric hematology unit with a multidisciplinary team.</p>\n </section>\n </div>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":"72 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pbc.31378","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Acute chest syndrome (ACS) is a life-threatening complication of sickle cell disease (SCD). The Prevent Acute Chest Syndrome checklist (PACScheck) was created to drive appropriate ordering of opioids, incentive spirometry (IS), intravenous fluids (IVF), evaluation of oxygen desaturation, and bronchodilator use.

Objectives

Decrease the development of ACS by 5% in a hospitalized pediatric SCD population.

Methods

A multidisciplinary team conducted a quality improvement (QI) project between April 2020 and August 2021 on an inpatient pediatric hematology unit. At-risk hospitalizations were patients with SCD who did not have ACS upon hospital admission. PACScheck was implemented and weekly run charts assessed documentation. Process control (p) charts, geometric control (g) charts, and chi-square tests assessed checklist process measures pre- and post-PACScheck. G chart assessed the number of encounters between ACS events.

Results

A total of 483 at-risk hospitalizations were identified in the 12 months prior and 363 during the study period. A g chart demonstrated that fewer encounters developed ACS during PACScheck. A p chart demonstrated that IS documentation increased during PACScheck. A run chart of PACScheck documentation demonstrated a median of 100% documentation at least once per hospitalization during the last six months of the intervention.

Conclusion

Development of ACS can be reduced by implementing a best-practices checklist (PACScheck) on an inpatient pediatric hematology unit with a multidisciplinary team.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预防急性胸部综合征检查表(PACScheck):减少急性胸部综合征的质量改进措施。
背景:急性胸部综合征 (ACS) 是镰状细胞病 (SCD) 的一种危及生命的并发症。创建预防急性胸部综合征检查表(PACScheck)的目的是推动阿片类药物、激励肺活量测定(IS)、静脉输液(IVF)、氧饱和度评估和支气管扩张剂使用的合理下单:目标:将儿科 SCD 住院患者的 ACS 发生率降低 5%:2020年4月至2021年8月期间,一个多学科团队在儿科血液科住院病房开展了一项质量改进(QI)项目。高危住院患者是指入院时未出现 ACS 的 SCD 患者。实施了 PACScheck,并每周对运行图进行评估记录。流程控制(P)图、几何控制(G)图和卡方检验评估了 PACScheck 前后的检查单流程措施。G 图表评估了两次 ACS 事件之间的接触次数:结果:研究前 12 个月共发现 483 例高风险住院病例,研究期间发现 363 例。G 图表显示,在 PACScheck 期间发生 ACS 的就诊次数减少。P图显示,PACScheck期间IS记录有所增加。PACScheck 记录的运行图显示,在干预的最后六个月中,每次住院至少一次记录的中位数为 100%:结论:在拥有多学科团队的儿科血液科住院病房实施最佳实践检查表(PACScheck)可减少 ACS 的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pediatric Blood & Cancer
Pediatric Blood & Cancer 医学-小儿科
CiteScore
4.90
自引率
9.40%
发文量
546
审稿时长
1.5 months
期刊介绍: Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
期刊最新文献
Association Between Perinatal Factors and Childhood Lymphoma-A Pooled Analysis of the ESCALE and ESTELLE Studies (SFCE). Delayed Presentation of Transfusion-Associated Circulatory Overload Associated With Splenic Sequestration Management in Sickle Cell Disease. Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome from 1995 to 2020. Issue Information Factors Influencing Guardians' Health-Seeking Decisions for Children With Burkitt Lymphoma in Northern and Central Malawi.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1